GlassScriptPhysician profile
Joshua M Lohri
NPI 1396964904
$8,295.65
in general payments reported to CMS, 2019-2025
19 companies · $665 in 2025
The $665 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,162 · 2020: $333 · 2021: $776 · 2022: $871 · 2023: $1,616 · 2024: $1,872 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,588 · Consulting Fee: $450 · Travel and Lodging: $80.39 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,588.24 |
| Consulting Fee | $450.00 |
| Travel and Lodging | $80.39 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,269.56 | 2019-2025 | Ams 700, Lithovue, Ams 700 Cxr Rte Kit |
| Coloplast Corp | $1,626.58 | 2019-2022 | |
| Medtronic USA, INC. | $631.30 | 2019-2020 | |
| Medtronic, INC. | $518.25 | 2021-2024 | Interstim |
| Axonics, INC. | $400.70 | 2022-2024 | Axonics |
| Astellas Pharma US INC | $211.81 | 2019-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $140.51 | 2023 | Gemtesa |
| Intuitive Surgical, INC. | $125.00 | 2025 | |
| Endo USA, INC. | $70.77 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $61.63 | 2022-2023 | Xiaflex |
| Pfizer INC. | $39.30 | 2024 | |
| Cook Medical LLC | $37.11 | 2025 | Cook |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Urogen Pharma, INC. | $27.21 | 2025 | |
| Myriad Genetic Laboratories, INC. | $23.87 | 2024 | Prolaris |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $21.99 | 2022 | |
| Halozyme INC | $20.60 | 2023 | |
| Olympus America INC. | $20.38 | 2022 | |
| Sagent Pharmaceuticals | $14.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Lohri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.